Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Duru N, Pawar NR, Martin EW, Buzza MS, et al. Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases. Proc Natl Acad Sci U S A 2022;119:e2201423119.
PMID: 35867758


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016